OACCU — Oaktree Acquisition Corp. III Life Sciences
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2029769 ·
Last close
$11.03
Market Cap
—
52W High
$12.47
52W Low
$10.68
ADV30
201
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -456,538 | 1,394,121 | 204,830,388 | 1,276,930 | 8,642,892 |
| Dec 2025 | 0 | — | -255,496 | 1,788,948 | 203,111,772 | 1,434,965 | 8,318,397 |
| Sep 2025 | 0 | — | -225,579 | 1,966,742 | 201,249,963 | 1,328,841 | 8,245,536 |
| Jun 2025 | 0 | — | -269,810 | 1,874,343 | 199,175,668 | 1,385,359 | 8,137,983 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-422,079
Investing CF
$250,000
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-6,770,695
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,195,687
Pretax Income TTM
$7,288,824
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,195,687 | 7,288,824 | 203,111,772 | 8,318,397 | — | -422,079 |
| Dec 2024 | — | — | — | 195,250,622 | 7,746,071 | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $5.27B | $41.21 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $641.46M | $10.07 | — |
| INV | Innventure, Inc. | $536.21M | $6.38 | — |
| BCSS | Bain Capital GSS Investment Corp. | $478.38M | $10.20 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $477.46M | $10.17 | — |
Recent Insider Activity
No insider activity indexed for this ticker.